Mapk9 | Rat | (+)-alpha-viniferin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | alpha-viniferin inhibits the reaction [MAPK9 protein results in increased phosphorylation of and results in increased activity of STAT1 protein] | CTD | PMID:20424383 |
Mapk9 | Rat | (-)-anisomycin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 and 4-d)pyrimidine inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15772366 |
Mapk9 | Rat | (-)-anisomycin | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Anisomycin results in increased phosphorylation of MAPK9 protein | CTD | PMID:15772366 and PMID:16038797 |
Mapk9 | Rat | (-)-anisomycin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Anisomycin results in increased phosphorylation of MAPK9 protein | CTD | PMID:12967334 and PMID:33075463 |
Mapk9 | Rat | (-)-citrinin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Citrinin results in increased phosphorylation of MAPK9 protein | CTD | PMID:19361540 |
Mapk9 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19944065 |
Mapk9 | Rat | (R)-noradrenaline | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Norepinephrine] | CTD | PMID:16949803 |
Mapk9 | Rat | (R)-noradrenaline | affects response to substance | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK9 protein affects the susceptibility to Norepinephrine | CTD | PMID:16949803 |
Mapk9 | Rat | (R,R,R)-alpha-tocopherol | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein | CTD | PMID:20686688 |
Mapk9 | Rat | (R,R,R)-alpha-tocopherol | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein] and salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20686688 |
Mapk9 | Rat | (S)-colchicine | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Colchicine results in increased phosphorylation of MAPK9 protein | CTD | PMID:12221076 |
Mapk9 | Rat | (S)-colchicine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | TP53 protein affects the reaction [Colchicine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:12221076 |
Mapk9 | Rat | (S)-naringenin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | naringenin results in increased phosphorylation of MAPK9 protein | CTD | PMID:27838343 |
Mapk9 | Rat | (S)-nicotine | decreases expression | EXP | | 6480464 | Nicotine results in decreased expression of MAPK9 mRNA | CTD | PMID:26776438 |
Mapk9 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [o and p'-DDT results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20678559 |
Mapk9 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | o and p'-DDT results in increased phosphorylation of MAPK9 protein | CTD | PMID:20678559 |
Mapk9 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | o more ... | CTD | PMID:18840457 |
Mapk9 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MAPK9 mRNA | CTD | PMID:22206623 |
Mapk9 | Rat | 1,3-dichloropropan-2-ol | increases phosphorylation | EXP | | 6480464 | 1 and 3-dichloro-2-propanol results in increased phosphorylation of MAPK9 protein | CTD | PMID:26143167 |
Mapk9 | Rat | 1,3-dichloropropan-2-ol | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [1 and 3-dichloro-2-propanol results in increased phosphorylation of MAPK9 protein] | CTD | PMID:29248572 |
Mapk9 | Rat | 1,3-dichloropropan-2-ol | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | 1 and 3-dichloro-2-propanol results in increased phosphorylation of MAPK9 protein | CTD | PMID:29248572 |
Mapk9 | Rat | 1,4-phenylenediamine | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | 4-phenylenediamine results in increased phosphorylation of MAPK9 protein | CTD | PMID:23172806 |
Mapk9 | Rat | 1,8-cineole | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Eucalyptol inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased phosphorylation of MAPK9 protein] | CTD | PMID:23872422 |
Mapk9 | Rat | 1-fluoro-2,4-dinitrobenzene | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein | CTD | PMID:27129696 |
Mapk9 | Rat | 1-fluoro-2,4-dinitrobenzene | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein] | CTD | PMID:27129696 |
Mapk9 | Rat | 17beta-estradiol | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of MAPK9 mRNA | CTD | PMID:23094148 |
Mapk9 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of MAPK9 mRNA | CTD | PMID:26496021 |
Mapk9 | Rat | 17beta-estradiol | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | IGF1R mutant form inhibits the reaction [Estradiol results in decreased expression of MAPK9 mRNA] | CTD | PMID:23094148 |
Mapk9 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | APOE gene polymorphism affects the reaction [Dihydrotestosterone affects the phosphorylation of MAPK9 protein] | CTD | PMID:17395708 |
Mapk9 | Rat | 2''-galloylhyperin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 2''-galloylhyperin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:28213291 |
Mapk9 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | MAPK9 affects the reaction [2 more ... | CTD | PMID:26519956 |
Mapk9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mapk9 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAPK9 mRNA | CTD | PMID:21570461 |
Mapk9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MAPK9 mRNA | CTD | PMID:34747641 |
Mapk9 | Rat | 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] promotes the reaction [BCL2L11 protein binds to MAPK9 protein] more ... | CTD | PMID:22427801 |
Mapk9 | Rat | 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein | CTD | PMID:22427801 |
Mapk9 | Rat | 2-aminobiphenyl | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of MAPK9 protein] | CTD | PMID:23836369 |
Mapk9 | Rat | 2-aminobiphenyl | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | 2-aminodiphenyl results in increased phosphorylation of MAPK9 protein | CTD | PMID:23836369 |
Mapk9 | Rat | 2-methyl-6-(phenylethynyl)pyridine | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 6-methyl-2-(phenylethynyl)pyridine promotes the reaction [Biological Products results in increased phosphorylation of MAPK9 protein] | CTD | PMID:29458170 |
Mapk9 | Rat | 3,3',5,5'-tetrabromobisphenol A | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK9 protein] and diphenyleneiodonium inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK9 protein] | CTD | PMID:30766661 |
Mapk9 | Rat | 3,3',5,5'-tetrabromobisphenol A | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in increased phosphorylation of MAPK9 protein | CTD | PMID:30766661 |
Mapk9 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of MAPK9 mRNA | CTD | PMID:26251327 |
Mapk9 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased phosphorylation of MAPK9 protein and pentagalloylglucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:30721698 |
Mapk9 | Rat | 3-O-Caffeoyl-1-O-methylquinic acid | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | 3-O-caffeoyl-1-methylquinic acid results in increased phosphorylation of MAPK9 protein | CTD | PMID:16631525 |
Mapk9 | Rat | 3-phenylprop-2-enal | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | cinnamaldehyde inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased phosphorylation of MAPK9 protein] | CTD | PMID:17868967 |
Mapk9 | Rat | 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 4 more ... | CTD | PMID:19815690 |
Mapk9 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of MAPK9 mRNA | CTD | PMID:38301581 |
Mapk9 | Rat | 4-hydroxynon-2-enal | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | 4-hydroxy-2-nonenal results in increased phosphorylation of MAPK9 protein | CTD | PMID:24825450 |
Mapk9 | Rat | 4-hydroxyphenyl retinamide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [IL24 protein co-treated with Fenretinide] results in increased phosphorylation of MAPK9 protein | CTD | PMID:15580305 |
Mapk9 | Rat | 4-nonylphenol | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | 4-nonylphenol analog results in increased phosphorylation of MAPK9 protein | CTD | PMID:27086933 |
Mapk9 | Rat | 4-phenylbutyric acid | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21147958 |
Mapk9 | Rat | 5-aza-2'-deoxycytidine | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Decitabine results in decreased expression of MAPK9 mRNA | CTD | PMID:27915011 |
Mapk9 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of MAPK9 mRNA | CTD | PMID:18077114 |
Mapk9 | Rat | acetaldehyde | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetaldehyde results in increased phosphorylation of MAPK9 protein | CTD | PMID:19110045 |
Mapk9 | Rat | acetaldehyde | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Hesperidin inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19110045 |
Mapk9 | Rat | acetaldehyde | increases activity | EXP | | 6480464 | Acetaldehyde results in increased activity of MAPK9 protein | CTD | PMID:10733585 |
Mapk9 | Rat | acrylamide | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein] and pyrazolanthrone inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25531190 |
Mapk9 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of MAPK9 protein modified form | CTD | PMID:29426002 |
Mapk9 | Rat | acrylamide | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Acrylamide results in increased phosphorylation of MAPK9 protein | CTD | PMID:25531190 |
Mapk9 | Rat | ADP | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Dicumarol inhibits the reaction [Adenosine Diphosphate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:24466103 |
Mapk9 | Rat | afimoxifene | decreases response to substance | ISO | MAPK9 (Homo sapiens) | 6480464 | MAPK9 results in decreased susceptibility to afimoxifene | CTD | PMID:21233418 |
Mapk9 | Rat | aflatoxin B1 | increases methylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MAPK9 intron | CTD | PMID:30157460 |
Mapk9 | Rat | aflatoxin B1 | decreases methylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of MAPK9 polyA tail | CTD | PMID:30157460 |
Mapk9 | Rat | Aflatoxin B2 alpha | decreases methylation | ISO | MAPK9 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of MAPK9 polyA tail | CTD | PMID:30157460 |
Mapk9 | Rat | aldehydo-D-glucose | increases phosphorylation | EXP | | 6480464 | Glucose results in increased phosphorylation of MAPK9 protein | CTD | PMID:19861503 |
Mapk9 | Rat | Alisol B | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | alisol B inhibits the reaction [[Dietary Fats co-treated with Carbon Tetrachloride] results in increased phosphorylation of MAPK9 protein] and alisol B inhibits the reaction [Palmitates results in increased phosphorylation of MAPK9 protein] | CTD | PMID:35745142 |
Mapk9 | Rat | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin results in decreased phosphorylation of and results in decreased activity of MAPK9 protein | CTD | PMID:16043492 |
Mapk9 | Rat | all-trans-retinoic acid | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MAPK9 mRNA | CTD | PMID:33167477 |
Mapk9 | Rat | all-trans-retinoic acid | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Tretinoin results in decreased expression of MAPK9 mRNA | CTD | PMID:22498432 |
Mapk9 | Rat | alpha-Chaconine | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | alpha-chaconine inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25913072 |
Mapk9 | Rat | alpha-mangostin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | mangostin analog results in increased phosphorylation of MAPK9 protein | CTD | PMID:28722351 |
Mapk9 | Rat | amidotrizoic acid | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Diatrizoate results in increased phosphorylation of MAPK9 protein | CTD | PMID:21036957 |
Mapk9 | Rat | amiloride | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein] | CTD | PMID:19815690 |
Mapk9 | Rat | amino acid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Amino Acids inhibits the reaction [KL gene mutant form results in increased phosphorylation of MAPK9 protein] and H 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in increased phosphorylation of MAPK9 protein]] | CTD | PMID:25309793 |
Mapk9 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MAPK9 mRNA | CTD | PMID:16483693 |
Mapk9 | Rat | ammonium chloride | multiple interactions | EXP | | 6480464 | TLR5 gene mutant form inhibits the reaction [Ammonium Chloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:30508503 |
Mapk9 | Rat | ammonium chloride | increases phosphorylation | EXP | | 6480464 | Ammonium Chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:30508503 |
Mapk9 | Rat | aniline | increases phosphorylation | EXP | | 6480464 | aniline results in increased phosphorylation of MAPK9 protein | CTD | PMID:16169568 and PMID:18420242 |
Mapk9 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:16687388 more ... |
Mapk9 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | pyrazolanthrone results in decreased phosphorylation of MAPK9 protein | CTD | PMID:34076342 |
Mapk9 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:18840457 more ... |
Mapk9 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | decreases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | pyrazolanthrone results in decreased activity of MAPK9 protein | CTD | PMID:12534346 |
Mapk9 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:15322261 more ... |
Mapk9 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | decreases phosphorylation | EXP | | 6480464 | pyrazolanthrone results in decreased phosphorylation of MAPK9 protein | CTD | PMID:22085843 |
Mapk9 | Rat | ANTIMYCIN | decreases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | antimycin results in decreased phosphorylation of MAPK9 protein | CTD | PMID:33290831 |
Mapk9 | Rat | antirheumatic drug | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of MAPK9 mRNA | CTD | PMID:24449571 |
Mapk9 | Rat | apigenin | multiple interactions | EXP | | 6480464 | Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25557508 |
Mapk9 | Rat | apocynin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | acetovanillone inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:21391979 more ... |
Mapk9 | Rat | arecoline | increases phosphorylation | EXP | | 6480464 | Arecoline results in increased phosphorylation of MAPK9 protein | CTD | PMID:34999050 |
Mapk9 | Rat | aristolochic acid A | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MAPK9 mRNA | CTD | PMID:33212167 |
Mapk9 | Rat | Aroclor 1254 | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of MAPK9 mRNA | CTD | PMID:23650126 |
Mapk9 | Rat | arsane | multiple interactions | EXP | | 6480464 | Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK9 protein more ... | CTD | PMID:11756236 and PMID:15210857 |
Mapk9 | Rat | arsane | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Arsenic results in increased expression of and results in increased phosphorylation of MAPK9 protein and SPD-304 inhibits the reaction [Arsenic results in increased expression of and results in increased phosphorylation of MAPK9 protein] | CTD | PMID:39098089 |
Mapk9 | Rat | arsane | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Arsenic results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:14633691 |
Mapk9 | Rat | arsenic atom | multiple interactions | EXP | | 6480464 | Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK9 protein more ... | CTD | PMID:11756236 and PMID:15210857 |
Mapk9 | Rat | arsenic atom | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Arsenic results in increased expression of and results in increased phosphorylation of MAPK9 protein and SPD-304 inhibits the reaction [Arsenic results in increased expression of and results in increased phosphorylation of MAPK9 protein] | CTD | PMID:39098089 |
Mapk9 | Rat | arsenic atom | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Arsenic results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:14633691 |
Mapk9 | Rat | arsenic trichloride | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK9 gene mutant form inhibits the reaction [arsenic trichloride results in increased phosphorylation of AKT1 protein] and MAPK9 gene mutant form inhibits the reaction [arsenic trichloride results in increased phosphorylation of STAT3 protein] | CTD | PMID:22696236 |
Mapk9 | Rat | arsenic trichloride | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | arsenic trichloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:22696236 and PMID:24434654 |
Mapk9 | Rat | arsenic trichloride | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | MAPK9 mutant form inhibits the reaction [arsenic trichloride results in increased expression of RIOX2 protein] more ... | CTD | PMID:22696236 and PMID:24434654 |
Mapk9 | Rat | arsenite(3-) | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | arsenite results in increased phosphorylation of MAPK9 protein | CTD | PMID:19808956 |
Mapk9 | Rat | arsenite(3-) | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [[[arsenite results in increased activity of PRKDC protein] which results in increased phosphorylation of and results in increased activity of MAPK9 protein] promotes the reaction [MAPK9 protein binds to TP53 protein]] inhibits the reaction [MDM2 results in increased degradation of and results in decreased stability of TP53 protein] more ... | CTD | PMID:22366412 |
Mapk9 | Rat | arsenite(3-) | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Arsenic Trioxide results in increased abundance of arsenite] which results in increased phosphorylation of MAPK9 protein and MAP3K8 protein affects the reaction [arsenite results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19808956 and PMID:36791901 |
Mapk9 | Rat | arsenous acid | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:15688020 |
Mapk9 | Rat | arsenous acid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Arsenic Trioxide results in increased abundance of arsenite] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:36791901 |
Mapk9 | Rat | arsenous acid | increases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased activity of MAPK9 protein | CTD | PMID:12296996 |
Mapk9 | Rat | arsenous acid | increases phosphorylation | EXP | | 6480464 | Arsenic Trioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:21145380 and PMID:27174766 |
Mapk9 | Rat | arsenous acid | increases response to substance | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK9 protein results in increased susceptibility to Arsenic Trioxide and MAPK9 results in increased susceptibility to Arsenic Trioxide | CTD | PMID:16818652 |
Mapk9 | Rat | arsenous acid | increases response to substance | ISO | MAPK9 (Homo sapiens) | 6480464 | MAPK9 results in increased susceptibility to Arsenic Trioxide | CTD | PMID:20799280 |
Mapk9 | Rat | arsenous acid | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:18412143 and PMID:24466103 |
Mapk9 | Rat | arsenous acid | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of MAPK9 protein | CTD | PMID:17374990 |
Mapk9 | Rat | arsenous acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Bortezomib co-treated with Arsenic Trioxide] affects the expression of MAPK9 protein more ... | CTD | PMID:15580305 more ... |
Mapk9 | Rat | arsenous acid | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein] and pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21145380 and PMID:27174766 |
Mapk9 | Rat | Azaspiracid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 4 more ... | CTD | PMID:19815690 |
Mapk9 | Rat | benzene | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | TRP53 protein inhibits the reaction [Benzene results in increased expression of MAPK9] | CTD | PMID:15935813 |
Mapk9 | Rat | benzo[a]pyrene | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MAPK9 mRNA | CTD | PMID:19770486 and PMID:21715664 |
Mapk9 | Rat | benzo[a]pyrene | increases methylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of MAPK9 promoter | CTD | PMID:27901495 |
Mapk9 | Rat | benzo[a]pyrene | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK9 protein] | CTD | PMID:18321868 |
Mapk9 | Rat | benzo[a]pyrene | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased phosphorylation of MAPK9 protein | CTD | PMID:18321868 |
Mapk9 | Rat | benzo[a]pyrene diol epoxide I | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 |
Mapk9 | Rat | beta-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19760616 |
Mapk9 | Rat | beta-hexachlorocyclohexane | increases phosphorylation | EXP | | 6480464 | beta-hexachlorocyclohexane results in increased phosphorylation of MAPK9 protein | CTD | PMID:19760616 |
Mapk9 | Rat | beta-lapachone | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of MAPK9 mRNA | CTD | PMID:38218311 |
Mapk9 | Rat | bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Mustard Gas results in increased phosphorylation of MAPK9 protein | CTD | PMID:18200059 |
Mapk9 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of MAPK9 mRNA | CTD | PMID:33754040 |
Mapk9 | Rat | bisphenol A | increases phosphorylation | EXP | | 6480464 | bisphenol A results in increased phosphorylation of MAPK9 protein | CTD | PMID:20096755 |
Mapk9 | Rat | bisphenol A | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | bisphenol A results in increased phosphorylation of MAPK9 protein | CTD | PMID:36232920 |
Mapk9 | Rat | bisphenol A | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of MAPK9 protein | CTD | PMID:34186270 |
Mapk9 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of MAPK9 mRNA | CTD | PMID:26496021 |
Mapk9 | Rat | Bisphenol A diglycidyl ether | multiple interactions | EXP | | 6480464 | bisphenol A diglycidyl ether inhibits the reaction [Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK9 protein]] | CTD | PMID:27274199 |
Mapk9 | Rat | bortezomib | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Bortezomib results in increased phosphorylation of MAPK9 protein | CTD | PMID:18559525 |
Mapk9 | Rat | bortezomib | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Bortezomib co-treated with arsenic trioxide] affects the expression of MAPK9 protein more ... | CTD | PMID:16985072 more ... |
Mapk9 | Rat | bufalin | decreases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | bufalin results in decreased activity of MAPK9 protein | CTD | PMID:21922632 |
Mapk9 | Rat | buspirone | decreases expression | EXP | | 6480464 | Buspirone results in decreased expression of MAPK9 mRNA | CTD | PMID:24136188 |
Mapk9 | Rat | C.I. Natural Red 20 | multiple interactions | EXP | | 6480464 | shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of MAPK9 protein] | CTD | PMID:35028790 |
Mapk9 | Rat | cadmium atom | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:15254339 more ... |
Mapk9 | Rat | cadmium atom | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Cadmium results in increased phosphorylation of MAPK9 protein | CTD | PMID:26187450 and PMID:26514923 |
Mapk9 | Rat | cadmium atom | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | acetovanillone inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:26187450 and PMID:26514923 |
Mapk9 | Rat | cadmium atom | affects response to substance | ISO | MAPK9 (Homo sapiens) | 6480464 | MAPK9 affects the susceptibility to Cadmium | CTD | PMID:10874022 |
Mapk9 | Rat | cadmium atom | affects response to substance | EXP | | 6480464 | MAPK9 protein affects the susceptibility to Cadmium | CTD | PMID:16516943 |
Mapk9 | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | Cadmium results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:16568437 |
Mapk9 | Rat | cadmium atom | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Cadmium results in increased phosphorylation of MAPK9 protein | CTD | PMID:15212812 and PMID:15254339 |
Mapk9 | Rat | cadmium dichloride | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:11958953 more ... |
Mapk9 | Rat | cadmium dichloride | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of MAPK9 protein modified form | CTD | PMID:24419708 |
Mapk9 | Rat | cadmium dichloride | increases phosphorylation | EXP | | 6480464 | Cadmium Chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:23876460 more ... |
Mapk9 | Rat | cadmium dichloride | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Cadmium Chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:11958953 |
Mapk9 | Rat | cadmium dichloride | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:10874044 and PMID:35122928 |
Mapk9 | Rat | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of MAPK9 promoter | CTD | PMID:22457795 |
Mapk9 | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:15618353 more ... |
Mapk9 | Rat | cadmium dichloride | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:12634122 more ... |
Mapk9 | Rat | cadmium sulfate | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK9 protein] and cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:14687664 |
Mapk9 | Rat | cadmium sulfate | increases phosphorylation | EXP | | 6480464 | cadmium sulfate results in increased phosphorylation of MAPK9 protein | CTD | PMID:22767315 |
Mapk9 | Rat | cadmium sulfate | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK9 protein] and Glutathione inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22767315 |
Mapk9 | Rat | caffeine | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of MAPK9 protein | CTD | PMID:35688186 |
Mapk9 | Rat | calcidiol | decreases expression | EXP | | 6480464 | Calcifediol deficiency results in decreased expression of MAPK9 mRNA | CTD | PMID:17293106 |
Mapk9 | Rat | calix[6]arene | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | calix(6)arene results in increased phosphorylation of MAPK9 protein | CTD | PMID:23872419 |
Mapk9 | Rat | camptothecin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Camptothecin results in increased phosphorylation of MAPK9 protein | CTD | PMID:15585644 |
Mapk9 | Rat | cantharidic acid | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | cantharidic acid results in increased phosphorylation of MAPK9 protein | CTD | PMID:29345422 |
Mapk9 | Rat | capsaicin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK9 protein] and Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21462327 and PMID:21745629 |
Mapk9 | Rat | capsaicin | increases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | Capsaicin results in increased activity of MAPK9 protein | CTD | PMID:9580328 |
Mapk9 | Rat | capsaicin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Capsaicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:20619260 |
Mapk9 | Rat | carbon nanotube | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of MAPK9 mRNA | CTD | PMID:25554681 |
Mapk9 | Rat | carnosic acid | multiple interactions | EXP | | 6480464 | salvin inhibits the reaction [Oxidopamine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25446857 |
Mapk9 | Rat | Carnosol | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | carnosol inhibits the reaction [Dietary Fats results in increased expression of MAPK9 protein modified form] more ... | CTD | PMID:34678374 |
Mapk9 | Rat | CGP 52608 | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MAPK9 gene] | CTD | PMID:28238834 |
Mapk9 | Rat | chenodeoxycholic acid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Chenodeoxycholic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] and Chenodeoxycholic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25496033 |
Mapk9 | Rat | chenodeoxycholic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA | CTD | PMID:32152650 |
Mapk9 | Rat | chlorpyrifos | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of MAPK9 mRNA | CTD | PMID:29156651 |
Mapk9 | Rat | choline | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAPK9 gene more ... | CTD | PMID:20938992 and PMID:23038002 |
Mapk9 | Rat | chromium atom | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Chromium inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21134603 |
Mapk9 | Rat | chromium(6+) | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Arsenates co-treated with chromium hexavalent ion] results in increased expression of MAPK9 protein more ... | CTD | PMID:19654923 and PMID:19895865 |
Mapk9 | Rat | chromium(6+) | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | chromium hexavalent ion results in increased phosphorylation of MAPK9 protein | CTD | PMID:19654923 and PMID:19895865 |
Mapk9 | Rat | chromium(6+) | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | chromium hexavalent ion results in increased expression of MAPK9 protein | CTD | PMID:19895865 |
Mapk9 | Rat | chromium(6+) | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | chromium hexavalent ion results in increased phosphorylation of MAPK9 protein | CTD | PMID:17045426 |
Mapk9 | Rat | chromones | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | N-(oxo-5 more ... | CTD | PMID:22583868 |
Mapk9 | Rat | chromones | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Chromones analog results in increased expression of MAPK9 protein modified form | CTD | PMID:22583868 |
Mapk9 | Rat | cisplatin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Cisplatin co-treated with 2 more ... | CTD | PMID:21214929 |
Mapk9 | Rat | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of MAPK9 protein modified form | CTD | PMID:26739623 |
Mapk9 | Rat | cisplatin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [Cisplatin results in increased expression of MAPK9 protein modified form] and N-Acetylcysteinamide inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15147517 and PMID:26739623 |
Mapk9 | Rat | cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of MAPK9 protein | CTD | PMID:15147517 |
Mapk9 | Rat | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPK9 mRNA | CTD | PMID:17602206 |
Mapk9 | Rat | clozapine | affects expression | EXP | | 6480464 | Clozapine affects the expression of MAPK9 mRNA | CTD | PMID:15860345 |
Mapk9 | Rat | cobalt dichloride | increases phosphorylation | EXP | | 6480464 | cobaltous chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:21925238 and PMID:22669716 |
Mapk9 | Rat | cobalt dichloride | multiple interactions | EXP | | 6480464 | Protein Kinase Inhibitors inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21925238 |
Mapk9 | Rat | cobalt dichloride | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | cobaltous chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:19101624 and PMID:24386346 |
Mapk9 | Rat | cobalt dichloride | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein] and ginsenoside Rg1 inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:24386346 |
Mapk9 | Rat | copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein more ... | CTD | PMID:22085843 |
Mapk9 | Rat | copper atom | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein and Copper inhibits the reaction [IAPP protein results in increased phosphorylation of MAPK9 protein] | CTD | PMID:23793354 and PMID:24690739 |
Mapk9 | Rat | copper atom | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:24690739 |
Mapk9 | Rat | copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein more ... | CTD | PMID:22085843 |
Mapk9 | Rat | copper(0) | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein and Copper inhibits the reaction [IAPP protein results in increased phosphorylation of MAPK9 protein] | CTD | PMID:23793354 and PMID:24690739 |
Mapk9 | Rat | copper(0) | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:24690739 |
Mapk9 | Rat | copper(II) sulfate | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of MAPK9 mRNA | CTD | PMID:19549813 |
Mapk9 | Rat | crocidolite asbestos | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased expression of and results in decreased phosphorylation of MAPK9 protein | CTD | PMID:17191120 |
Mapk9 | Rat | curcumin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK9 protein] and Curcumin inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein] | CTD | PMID:18321868 and PMID:34272803 |
Mapk9 | Rat | curcumin | decreases phosphorylation | EXP | | 6480464 | Curcumin results in decreased phosphorylation of MAPK9 protein | CTD | PMID:18332871 |
Mapk9 | Rat | curcumin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Curcumin results in increased phosphorylation of MAPK9 protein | CTD | PMID:18316600 |
Mapk9 | Rat | curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [sodium arsenite results in increased expression of MAPK9 protein] more ... | CTD | PMID:11981161 more ... |
Mapk9 | Rat | cyclophosphamide | multiple interactions | EXP | | 6480464 | Cyclophosphamide results in increased phosphorylation of and results in increased activity of MAPK9 protein and NGF protein affects the reaction [Cyclophosphamide results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:19996110 |
Mapk9 | Rat | cyclosporin A | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MAPK9 mRNA | CTD | PMID:20106945 and PMID:32152650 |
Mapk9 | Rat | cyclosporin A | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA | CTD | PMID:32152650 |
Mapk9 | Rat | cypermethrin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein | CTD | PMID:29471534 |
Mapk9 | Rat | D-glucitol | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Sorbitol results in increased phosphorylation of MAPK9 protein | CTD | PMID:24184208 |
Mapk9 | Rat | D-glucose | increases phosphorylation | EXP | | 6480464 | Glucose results in increased phosphorylation of MAPK9 protein | CTD | PMID:19861503 |
Mapk9 | Rat | DDT | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | DDT results in decreased phosphorylation of MAPK9 protein | CTD | PMID:14604893 |
Mapk9 | Rat | deoxycholic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA | CTD | PMID:32152650 |
Mapk9 | Rat | Deoxycorticosterone acetate | multiple interactions | EXP | | 6480464 | chromium mesoporphyrin inhibits the reaction [heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of MAPK9 mRNA]] more ... | CTD | PMID:23089228 |
Mapk9 | Rat | Deoxycorticosterone acetate | increases expression | EXP | | 6480464 | Desoxycorticosterone Acetate results in increased expression of MAPK9 mRNA | CTD | PMID:23089228 |
Mapk9 | Rat | deoxynivalenol | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 more ... | CTD | PMID:14644621 more ... |
Mapk9 | Rat | deoxynivalenol | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | deoxynivalenol results in increased phosphorylation of MAPK9 protein | CTD | PMID:20633634 |
Mapk9 | Rat | deoxynivalenol | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [deoxynivalenol results in increased expression of DUSP1 protein] which results in decreased activity of MAPK9 protein and deoxynivalenol results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:18485432 more ... |
Mapk9 | Rat | deoxynivalenol | decreases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | deoxynivalenol results in decreased activity of MAPK9 protein | CTD | PMID:20708668 |
Mapk9 | Rat | deoxynivalenol | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | deoxynivalenol results in increased phosphorylation of MAPK9 protein | CTD | PMID:12377986 more ... |
Mapk9 | Rat | deoxynivalenol | decreases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | deoxynivalenol results in decreased phosphorylation of MAPK9 protein | CTD | PMID:23352502 |
Mapk9 | Rat | deoxynivalenol | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | deoxynivalenol results in decreased expression of MAPK9 mRNA | CTD | PMID:15371230 |
Mapk9 | Rat | desferrioxamine B | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Deferoxamine results in increased phosphorylation of MAPK9 protein | CTD | PMID:20368581 |
Mapk9 | Rat | desferrioxamine B | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Deferoxamine inhibits the reaction [Plant Extracts results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20206247 |
Mapk9 | Rat | dexamethasone | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased phosphorylation of MAPK9 protein more ... | CTD | PMID:27568862 more ... |
Mapk9 | Rat | diarsenic trioxide | increases response to substance | ISO | MAPK9 (Homo sapiens) | 6480464 | MAPK9 results in increased susceptibility to Arsenic Trioxide | CTD | PMID:20799280 |
Mapk9 | Rat | diarsenic trioxide | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Arsenic Trioxide results in increased abundance of arsenite] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:36791901 |
Mapk9 | Rat | diarsenic trioxide | increases response to substance | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK9 protein results in increased susceptibility to Arsenic Trioxide and MAPK9 results in increased susceptibility to Arsenic Trioxide | CTD | PMID:16818652 |
Mapk9 | Rat | diarsenic trioxide | increases phosphorylation | EXP | | 6480464 | Arsenic Trioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:21145380 and PMID:27174766 |
Mapk9 | Rat | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein] and pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21145380 and PMID:27174766 |
Mapk9 | Rat | diarsenic trioxide | increases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased activity of MAPK9 protein | CTD | PMID:12296996 |
Mapk9 | Rat | diarsenic trioxide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Bortezomib co-treated with Arsenic Trioxide] affects the expression of MAPK9 protein more ... | CTD | PMID:15580305 more ... |
Mapk9 | Rat | diarsenic trioxide | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:18412143 and PMID:24466103 |
Mapk9 | Rat | diarsenic trioxide | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of MAPK9 protein | CTD | PMID:17374990 |
Mapk9 | Rat | diarsenic trioxide | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:15688020 |
Mapk9 | Rat | dibenziodolium | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | diphenyleneiodonium inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:21391979 more ... |
Mapk9 | Rat | Dibutyl phosphate | affects expression | ISO | MAPK9 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of MAPK9 mRNA | CTD | PMID:37042841 |
Mapk9 | Rat | dichromium trioxide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA | CTD | PMID:12634122 |
Mapk9 | Rat | dicoumarol | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Dicumarol inhibits the reaction [Adenosine Diphosphate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:24466103 |
Mapk9 | Rat | diethyl maleate | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [diethyl maleate results in increased expression of MAPK9 protein modified form] | CTD | PMID:30261343 |
Mapk9 | Rat | diethyl maleate | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | diethyl maleate results in increased expression of MAPK9 protein modified form | CTD | PMID:30261343 |
Mapk9 | Rat | dioscin | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | dioscin results in increased expression of MAPK9 mRNA | CTD | PMID:29990575 |
Mapk9 | Rat | dioxygen | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | MAPK9 protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 protein] and TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19196431 and PMID:20812253 |
Mapk9 | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK9 protein more ... | CTD | PMID:27274199 |
Mapk9 | Rat | dioxygen | increases phosphorylation | EXP | | 6480464 | Oxygen results in increased phosphorylation of MAPK9 protein | CTD | PMID:20812253 |
Mapk9 | Rat | dioxygen | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased phosphorylation of MAPK9 protein | CTD | PMID:19196431 |
Mapk9 | Rat | diquat | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | PROP1 protein affects the reaction [Diquat affects the phosphorylation of MAPK9 protein] | CTD | PMID:20826540 |
Mapk9 | Rat | disodium selenite | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK9 protein] and Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:18728404 |
Mapk9 | Rat | disodium selenite | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26522834 |
Mapk9 | Rat | disodium selenite | affects expression | EXP | | 6480464 | Sodium Selenite affects the expression of MAPK9 | CTD | PMID:18209489 |
Mapk9 | Rat | disodium selenite | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of MAPK9 protein | CTD | PMID:18728404 |
Mapk9 | Rat | disulfiram | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:24690739 |
Mapk9 | Rat | disulfiram | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:24690739 |
Mapk9 | Rat | dobutamine | multiple interactions | EXP | | 6480464 | [Dobutamine co-treated with ICI 118551] results in increased activity of MAPK9 protein | CTD | PMID:19719783 |
Mapk9 | Rat | donepezil hydrochloride | multiple interactions | EXP | | 6480464 | Donepezil inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of MAPK9 protein] | CTD | PMID:19345205 |
Mapk9 | Rat | dorsomorphin | multiple interactions | EXP | | 6480464 | dorsomorphin inhibits the reaction [Resveratrol results in decreased expression of MAPK9 protein modified form] | CTD | PMID:27093858 |
Mapk9 | Rat | doxorubicin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:15494689 more ... |
Mapk9 | Rat | doxorubicin | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of MAPK9 mRNA | CTD | PMID:29803840 |
Mapk9 | Rat | doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:16213474 more ... |
Mapk9 | Rat | doxorubicin | multiple interactions | EXP | | 6480464 | [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:16687611 more ... |
Mapk9 | Rat | doxorubicin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Doxorubicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:15557793 more ... |
Mapk9 | Rat | ebselen | increases phosphorylation | EXP | | 6480464 | ebselen results in increased phosphorylation of MAPK9 protein | CTD | PMID:27282967 |
Mapk9 | Rat | elemental selenium | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Selenium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26187450 |
Mapk9 | Rat | ellagic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Ellagic Acid co-treated with Quercetin] results in increased phosphorylation of MAPK9 protein | CTD | PMID:15735102 |
Mapk9 | Rat | emetine | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 and 4-d)pyrimidine inhibits the reaction [Emetine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15772366 |
Mapk9 | Rat | emetine | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Emetine results in increased phosphorylation of MAPK9 protein | CTD | PMID:15772366 |
Mapk9 | Rat | enalapril | increases expression | EXP | | 6480464 | Enalapril results in increased expression of MAPK9 mRNA and Enalapril results in increased expression of MAPK9 protein | CTD | PMID:15531746 |
Mapk9 | Rat | enalapril | increases phosphorylation | EXP | | 6480464 | Enalapril results in increased phosphorylation of MAPK9 protein | CTD | PMID:15531746 |
Mapk9 | Rat | enzyme inhibitor | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MAPK9 protein | CTD | PMID:23301498 |
Mapk9 | Rat | esculetin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [esculetin co-treated with Paclitaxel] results in increased expression of MAPK9 protein | CTD | PMID:16051289 |
Mapk9 | Rat | esculetin | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | esculetin results in increased expression of MAPK9 protein | CTD | PMID:16051289 |
Mapk9 | Rat | estragole | increases phosphorylation | EXP | | 6480464 | estragole results in increased phosphorylation of MAPK9 protein | CTD | PMID:29054680 |
Mapk9 | Rat | ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of MAPK9 mRNA | CTD | PMID:11772933 |
Mapk9 | Rat | ethanol | affects splicing | ISO | Mapk9 (Mus musculus) | 6480464 | Ethanol affects the splicing of MAPK9 mRNA | CTD | PMID:30319688 |
Mapk9 | Rat | ethanol | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Ethanol results in increased phosphorylation of MAPK9 protein | CTD | PMID:28062356 |
Mapk9 | Rat | ethanol | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Ethanol results in increased phosphorylation of MAPK9 protein | CTD | PMID:28119953 |
Mapk9 | Rat | Ethyl pyruvate | multiple interactions | EXP | | 6480464 | ethyl pyruvate inhibits the reaction [Phosgene results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21818760 |
Mapk9 | Rat | ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | EXP | | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] and Egtazic Acid inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:11981161 and PMID:21544200 |
Mapk9 | Rat | ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] and Egtazic Acid inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15254339 and PMID:21544200 |
Mapk9 | Rat | ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
Mapk9 | Rat | Evodiamine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:23774672 |
Mapk9 | Rat | Evodiamine | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | evodiamine results in increased expression of MAPK9 protein modified form | CTD | PMID:23774672 |
Mapk9 | Rat | ferrosoferric oxide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Ferrosoferric Oxide binds to titanium dioxide] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:30098274 |
Mapk9 | Rat | fluorescein 5-isothiocyanate | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein] and Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:27129696 |
Mapk9 | Rat | fluorescein 5-isothiocyanate | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK9 protein | CTD | PMID:27129696 |
Mapk9 | Rat | flutamide | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Flutamide results in increased expression of MAPK9 mRNA | CTD | PMID:32662666 |
Mapk9 | Rat | folic acid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAPK9 gene | CTD | PMID:20938992 |
Mapk9 | Rat | fomepizole | affects binding | ISO | Mapk9 (Mus musculus) | 6480464 | Fomepizole binds to MAPK9 protein | CTD | PMID:30903181 |
Mapk9 | Rat | formaldehyde | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of MAPK9 mRNA | CTD | PMID:23649840 |
Mapk9 | Rat | formoterol fumarate | multiple interactions | EXP | | 6480464 | Formoterol Fumarate inhibits the reaction [dinitrophenyl-bovine serum albumin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26003274 |
Mapk9 | Rat | fucoxanthin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | fucoxanthin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:35616142 |
Mapk9 | Rat | Fulvic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25888188 |
Mapk9 | Rat | galangin | multiple interactions | EXP | | 6480464 | galangin inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:35843304 |
Mapk9 | Rat | gallic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Gallic Acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21420233 |
Mapk9 | Rat | gamma-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | Hexachlorocyclohexane results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:23927878 |
Mapk9 | Rat | Geniposide pentaacetate | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [pentaacetyl geniposide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:17651887 |
Mapk9 | Rat | Geniposide pentaacetate | increases phosphorylation | EXP | | 6480464 | pentaacetyl geniposide results in increased phosphorylation of MAPK9 protein | CTD | PMID:17651887 |
Mapk9 | Rat | gentamycin | multiple interactions | EXP | | 6480464 | Gentamicins inhibits the reaction [lipoxin A4 results in increased phosphorylation of MAPK9 protein] | CTD | PMID:36057361 |
Mapk9 | Rat | ginsenoside Rg1 | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | ginsenoside Rg1 inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:24386346 |
Mapk9 | Rat | glucose | increases phosphorylation | EXP | | 6480464 | Glucose results in increased phosphorylation of MAPK9 protein | CTD | PMID:19861503 |
Mapk9 | Rat | glutathione | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Glutathione inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20423716 |
Mapk9 | Rat | glutathione | multiple interactions | EXP | | 6480464 | Glutathione inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22767315 |
Mapk9 | Rat | glycochenodeoxycholic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA | CTD | PMID:32152650 |
Mapk9 | Rat | glycocholic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA | CTD | PMID:32152650 |
Mapk9 | Rat | glycodeoxycholic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA | CTD | PMID:32152650 |
Mapk9 | Rat | GW 4064 | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | GW 4064 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:25496033 |
Mapk9 | Rat | GW 4064 | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | GW 4064 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] and GW 4064 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25496033 |
Mapk9 | Rat | haloperidol | affects expression | EXP | | 6480464 | Haloperidol affects the expression of MAPK9 mRNA | CTD | PMID:15860345 |
Mapk9 | Rat | hemin | multiple interactions | EXP | | 6480464 | chromium mesoporphyrin inhibits the reaction [Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA]] and Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA] | CTD | PMID:19190261 |
Mapk9 | Rat | hemin | decreases expression | EXP | | 6480464 | Hemin results in decreased expression of MAPK9 mRNA | CTD | PMID:20016031 |
Mapk9 | Rat | hesperidin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Hesperidin inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19110045 |
Mapk9 | Rat | hexadecanoic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21745629 |
Mapk9 | Rat | hexadecanoic acid | multiple interactions | EXP | | 6480464 | 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK9 protein]] and Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:25109277 |
Mapk9 | Rat | hexadecanoic acid | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Palmitic Acid results in increased phosphorylation of MAPK9 protein | CTD | PMID:21134603 and PMID:34678374 |
Mapk9 | Rat | hexadecanoic acid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | carnosol inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:21134603 and PMID:34678374 |
Mapk9 | Rat | hexadecanoic acid | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Palmitic Acid results in increased phosphorylation of MAPK9 protein | CTD | PMID:21745629 |
Mapk9 | Rat | hexamethylene diisocyanate | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 1 and 6-hexamethylene diisocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:27129696 |
Mapk9 | Rat | hexamethylene diisocyanate | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | 1 and 6-hexamethylene diisocyanate results in increased phosphorylation of MAPK9 protein | CTD | PMID:27129696 |
Mapk9 | Rat | homocysteine | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Homocysteine results in increased phosphorylation of MAPK9 protein | CTD | PMID:25888188 |
Mapk9 | Rat | homocysteine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25888188 |
Mapk9 | Rat | hydrogen peroxide | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in decreased expression of MAPK9 mRNA | CTD | PMID:12419474 |
Mapk9 | Rat | hydrogen peroxide | increases phosphorylation | EXP | | 6480464 | Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:16362428 more ... |
Mapk9 | Rat | hydrogen peroxide | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:25496033 and PMID:33290831 |
Mapk9 | Rat | hydrogen peroxide | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Chenodeoxycholic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] and GW 4064 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25496033 |
Mapk9 | Rat | hydrogen peroxide | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:15795422 more ... |
Mapk9 | Rat | hydrogen peroxide | increases activity | ISO | Mapk9 (Mus musculus) | 6480464 | Hydrogen Peroxide results in increased activity of MAPK9 protein | CTD | PMID:11181820 and PMID:14975446 |
Mapk9 | Rat | hydrogen peroxide | increases activity | EXP | | 6480464 | Hydrogen Peroxide results in increased activity of MAPK9 protein | CTD | PMID:15574683 |
Mapk9 | Rat | hydrogen peroxide | multiple interactions | EXP | | 6480464 | 2-(4-((dimethylamino)methyl)benzylidene)-5 more ... | CTD | PMID:15574683 more ... |
Mapk9 | Rat | hydrogen peroxide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 2''-galloylhyperin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:15795422 more ... |
Mapk9 | Rat | hydrogen sulfide | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Hydrogen Sulfide results in increased phosphorylation of MAPK9 protein | CTD | PMID:31843631 |
Mapk9 | Rat | hypochlorous acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Hypochlorous Acid results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:18156441 |
Mapk9 | Rat | ibuprofen | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Ibuprofen results in increased expression of MAPK9 mRNA | CTD | PMID:37453669 |
Mapk9 | Rat | ICI 118551 | multiple interactions | EXP | | 6480464 | [Dobutamine co-treated with ICI 118551] results in increased activity of MAPK9 protein | CTD | PMID:19719783 |
Mapk9 | Rat | indoxyl sulfate | increases phosphorylation | EXP | | 6480464 | Indican results in increased phosphorylation of MAPK9 protein | CTD | PMID:32045570 |
Mapk9 | Rat | iomeprol | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | iomeprol results in increased phosphorylation of MAPK9 protein | CTD | PMID:21036957 |
Mapk9 | Rat | kaempferol | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | kaempferol results in increased phosphorylation of MAPK9 protein | CTD | PMID:30499162 |
Mapk9 | Rat | KT 5823 | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | KT 5823 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:35122928 |
Mapk9 | Rat | L-ascorbic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with Eosine I Bluish] results in increased phosphorylation of MAPK9 protein more ... | CTD | PMID:20206247 and PMID:24488945 |
Mapk9 | Rat | L-cysteine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Cysteine deficiency] results in increased activity of MAPK9 protein | CTD | PMID:11709198 |
Mapk9 | Rat | L-glutamic acid | multiple interactions | EXP | | 6480464 | shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of MAPK9 protein] | CTD | PMID:35028790 |
Mapk9 | Rat | L-glutamic acid | increases phosphorylation | EXP | | 6480464 | Glutamic Acid results in increased phosphorylation of MAPK9 protein | CTD | PMID:35028790 |
Mapk9 | Rat | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Cysteine deficiency] results in increased activity of MAPK9 protein | CTD | PMID:11709198 |
Mapk9 | Rat | L-methionine | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAPK9 gene more ... | CTD | PMID:20938992 and PMID:23038002 |
Mapk9 | Rat | lead diacetate | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA | CTD | PMID:12634122 |
Mapk9 | Rat | lead diacetate | increases phosphorylation | EXP | | 6480464 | lead acetate results in increased phosphorylation of MAPK9 protein | CTD | PMID:25088297 |
Mapk9 | Rat | lead diacetate | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:20829427 and PMID:25088297 |
Mapk9 | Rat | lead(0) | affects expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Lead affects the expression of MAPK9 mRNA | CTD | PMID:28903495 |
Mapk9 | Rat | lead(II) chloride | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | lead chloride results in increased expression of MAPK9 protein modified form | CTD | PMID:24419708 |
Mapk9 | Rat | Licochalcone A | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | licochalcone A promotes the reaction [Sorafenib results in decreased phosphorylation of MAPK9 protein] and Sorafenib promotes the reaction [licochalcone A results in decreased phosphorylation of MAPK9 protein] | CTD | PMID:30187994 |
Mapk9 | Rat | Licochalcone A | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | licochalcone A results in decreased phosphorylation of MAPK9 protein | CTD | PMID:30187994 |
Mapk9 | Rat | Licochalcone B | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25451593 |
Mapk9 | Rat | Licochalcone B | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | licochalcone B results in increased phosphorylation of MAPK9 protein | CTD | PMID:35948134 |
Mapk9 | Rat | lipopolysaccharide | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased phosphorylation of MAPK9 protein | CTD | PMID:14644621 more ... |
Mapk9 | Rat | lipopolysaccharide | increases phosphorylation | EXP | | 6480464 | Lipopolysaccharides results in increased phosphorylation of MAPK9 protein | CTD | PMID:25557508 |
Mapk9 | Rat | lipopolysaccharide | multiple interactions | EXP | | 6480464 | Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25557508 |
Mapk9 | Rat | lipopolysaccharide | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of MAPK9 mRNA more ... | CTD | PMID:15832817 more ... |
Mapk9 | Rat | lipopolysaccharide | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 2'-hydroxyflavanone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:14644621 more ... |
Mapk9 | Rat | lipopolysaccharide | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased phosphorylation of MAPK9 protein | CTD | PMID:21911040 more ... |
Mapk9 | Rat | lipopolysaccharide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:21391979 more ... |
Mapk9 | Rat | lipoxin A4 | increases phosphorylation | EXP | | 6480464 | lipoxin A4 results in increased phosphorylation of MAPK9 protein | CTD | PMID:36057361 |
Mapk9 | Rat | lipoxin A4 | multiple interactions | EXP | | 6480464 | Gentamicins inhibits the reaction [lipoxin A4 results in increased phosphorylation of MAPK9 protein] | CTD | PMID:36057361 |
Mapk9 | Rat | lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of MAPK9 protein | CTD | PMID:18296634 |
Mapk9 | Rat | lithium hydride | increases expression | EXP | | 6480464 | Lithium results in increased expression of MAPK9 protein | CTD | PMID:18296634 |
Mapk9 | Rat | Longikaurin A | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [longikaurin A results in increased phosphorylation of MAPK9 protein] | CTD | PMID:28801140 |
Mapk9 | Rat | Longikaurin A | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | longikaurin A results in increased phosphorylation of MAPK9 protein | CTD | PMID:28801140 |
Mapk9 | Rat | lovastatin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [Cisplatin results in increased expression of MAPK9 protein modified form] | CTD | PMID:26739623 |
Mapk9 | Rat | luteolin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Luteolin results in increased phosphorylation of MAPK9 protein | CTD | PMID:21601631 |
Mapk9 | Rat | luteolin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Luteolin analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:30133131 |
Mapk9 | Rat | LY294002 | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of MAPK9 protein | CTD | PMID:14688022 |
Mapk9 | Rat | LY294002 | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Triclosan results in increased phosphorylation of MAPK9 protein] | CTD | PMID:34160118 |
Mapk9 | Rat | LY294002 | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26385185 |
Mapk9 | Rat | LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:16018989 |
Mapk9 | Rat | Maduramicin | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | maduramicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:31229567 |
Mapk9 | Rat | Maduramicin | increases phosphorylation | EXP | | 6480464 | maduramicin results in increased phosphorylation of MAPK9 protein | CTD | PMID:31229567 |
Mapk9 | Rat | Maduramicin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [maduramicin results in increased phosphorylation of MAPK9 protein] and PPP5C protein inhibits the reaction [maduramicin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:31229567 |
Mapk9 | Rat | Magnolol | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | magnolol inhibits the reaction [trimethyltin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26756313 |
Mapk9 | Rat | Malonoben | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | tyrphostin A9 inhibits the reaction [S100A4 protein results in increased phosphorylation of MAPK9 protein] | CTD | PMID:16948116 |
Mapk9 | Rat | manganese atom | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Manganese results in increased phosphorylation of MAPK9 protein | CTD | PMID:17045426 and PMID:22561169 |
Mapk9 | Rat | manganese atom | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22561169 |
Mapk9 | Rat | manganese(0) | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Manganese results in increased phosphorylation of MAPK9 protein | CTD | PMID:17045426 and PMID:22561169 |
Mapk9 | Rat | manganese(0) | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22561169 |
Mapk9 | Rat | manganese(II) chloride | increases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | manganese chloride results in increased activity of MAPK9 protein | CTD | PMID:20152896 |
Mapk9 | Rat | manganese(II) chloride | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | manganese chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:19084589 and PMID:20152896 |
Mapk9 | Rat | mangiferin | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | mangiferin results in decreased expression of MAPK9 mRNA | CTD | PMID:15135318 |
Mapk9 | Rat | manumycin A | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | manumycin inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:19739265 |
Mapk9 | Rat | masoprocol | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK9 protein modified form] | CTD | PMID:17395008 |
Mapk9 | Rat | mebendazole | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Mebendazole results in increased phosphorylation of MAPK9 protein | CTD | PMID:20848085 |
Mapk9 | Rat | mechlorethamine | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Mechlorethamine results in increased phosphorylation of MAPK9 protein | CTD | PMID:25891025 |
Mapk9 | Rat | melamine | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | melamine results in increased expression of MAPK9 mRNA | CTD | PMID:34842327 |
Mapk9 | Rat | mercury dichloride | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Mercuric Chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:10861847 |
Mapk9 | Rat | metformin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Metformin inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK9 protein] | CTD | PMID:16385087 |
Mapk9 | Rat | methamphetamine | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Methamphetamine results in increased phosphorylation of MAPK9 protein | CTD | PMID:32768653 |
Mapk9 | Rat | methotrexate | increases phosphorylation | EXP | | 6480464 | Methotrexate results in increased phosphorylation of MAPK9 protein | CTD | PMID:20885979 |
Mapk9 | Rat | methotrexate | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of MAPK9 mRNA | CTD | PMID:22183962 |
Mapk9 | Rat | methotrexate | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | MAPK9 gene mutant form inhibits the reaction [Methotrexate results in increased expression of TP53 protein] | CTD | PMID:22183962 |
Mapk9 | Rat | Methylazoxymethanol acetate | increases expression | EXP | | 6480464 | Methylazoxymethanol Acetate results in increased expression of MAPK9 mRNA | CTD | PMID:28349193 |
Mapk9 | Rat | methylglyoxal | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Pyruvaldehyde results in increased phosphorylation of MAPK9 protein | CTD | PMID:25933243 |
Mapk9 | Rat | methylglyoxal | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | sulforaphane inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25933243 |
Mapk9 | Rat | methylmercury chloride | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | methylmercuric chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:27667695 |
Mapk9 | Rat | methylseleninic acid | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | methylselenic acid results in decreased expression of MAPK9 mRNA | CTD | PMID:11830524 |
Mapk9 | Rat | microcystin-LR | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of MAPK9 mRNA | CTD | PMID:17654400 |
Mapk9 | Rat | microcystin-LR | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [IGBP1 protein results in increased susceptibility to cyanoginosin LR] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:29984889 |
Mapk9 | Rat | MitoTEMPO | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | MitoTEMPO inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] | CTD | PMID:33290831 |
Mapk9 | Rat | mycophenolic acid | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Mycophenolic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20302854 |
Mapk9 | Rat | mycophenolic acid | decreases expression | EXP | | 6480464 | Mycophenolic Acid results in decreased expression of MAPK9 protein modified form | CTD | PMID:20302854 |
Mapk9 | Rat | myricetin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | myricetin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK9 protein] and myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:17693661 |
Mapk9 | Rat | N(6),N(6)-dimethyladenine | multiple interactions | EXP | | 6480464 | N(6) and N(6)-dimethyladenine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:15618353 |
Mapk9 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK9 mRNA]] more ... | CTD | PMID:14687664 more ... |
Mapk9 | Rat | N-acetyl-L-cysteine | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetylcysteine results in decreased phosphorylation of MAPK9 protein | CTD | PMID:24735948 |
Mapk9 | Rat | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:19760616 more ... |
Mapk9 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [2 more ... | CTD | PMID:18412143 more ... |
Mapk9 | Rat | N-acetylsphingosine | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:18270325 |
Mapk9 | Rat | N-acetylsphingosine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein and TXNIP affects the reaction [N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:18270325 |
Mapk9 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK9 inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PMAIP1 mRNA] | CTD | PMID:23593480 |
Mapk9 | Rat | N-methyl-4-phenylpyridinium | increases activity | ISO | Mapk9 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased activity of MAPK9 protein | CTD | PMID:11181820 |
Mapk9 | Rat | N-methyl-4-phenylpyridinium | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAPK9 protein | CTD | PMID:20946892 |
Mapk9 | Rat | N-methyl-4-phenylpyridinium | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 8-phenyl-6a more ... | CTD | PMID:20946892 |
Mapk9 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of MAPK9 mRNA | CTD | PMID:25234470 |
Mapk9 | Rat | N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Methylnitronitrosoguanidine results in increased expression of MAPK9 mRNA | CTD | PMID:12634122 |
Mapk9 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPK9 mRNA | CTD | PMID:17602206 |
Mapk9 | Rat | N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | Dimethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK9 protein | CTD | PMID:12971962 |
Mapk9 | Rat | naringin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | naringin inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK9 protein] | CTD | PMID:22198281 |
Mapk9 | Rat | nickel dichloride | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [nickel chloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21843586 |
Mapk9 | Rat | nickel dichloride | increases phosphorylation | EXP | | 6480464 | nickel chloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:21843586 |
Mapk9 | Rat | nickel sulfate | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | nickel sulfate results in increased phosphorylation of MAPK9 protein | CTD | PMID:15588916 and PMID:19101624 |
Mapk9 | Rat | niclosamide | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:28824321 |
Mapk9 | Rat | nicotine | decreases expression | EXP | | 6480464 | Nicotine results in decreased expression of MAPK9 mRNA | CTD | PMID:26776438 |
Mapk9 | Rat | nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of MAPK9 mRNA | CTD | PMID:24136188 |
Mapk9 | Rat | nitroprusside | decreases expression | EXP | | 6480464 | Nitroprusside results in decreased expression of MAPK9 protein modified form | CTD | PMID:20132804 |
Mapk9 | Rat | nocodazole | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Nocodazole results in increased phosphorylation of MAPK9 protein | CTD | PMID:12221076 |
Mapk9 | Rat | nocodazole | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of MAPK9 protein] | CTD | PMID:12221076 |
Mapk9 | Rat | NORCANTHARIDIN | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | norcantharidin results in increased phosphorylation of MAPK9 protein | CTD | PMID:29193574 |
Mapk9 | Rat | notoginsenoside R1 | multiple interactions | EXP | | 6480464 | notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased phosphorylation of MAPK9 protein] | CTD | PMID:24975829 |
Mapk9 | Rat | ochratoxin A | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | ochratoxin A results in decreased phosphorylation of MAPK9 protein | CTD | PMID:25002221 |
Mapk9 | Rat | olmesartan | decreases activity | ISO | Mapk9 (Mus musculus) | 6480464 | olmesartan results in decreased activity of MAPK9 protein | CTD | PMID:17208988 |
Mapk9 | Rat | olmesartan | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | olmesartan results in decreased expression of MAPK9 protein modified form | CTD | PMID:17208988 |
Mapk9 | Rat | osthole | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | osthol results in increased phosphorylation of MAPK9 protein | CTD | PMID:29319219 |
Mapk9 | Rat | oxidopamine | increases phosphorylation | EXP | | 6480464 | Oxidopamine results in increased phosphorylation of MAPK9 protein | CTD | PMID:25446857 |
Mapk9 | Rat | oxidopamine | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Oxidopamine results in increased phosphorylation of MAPK9 protein | CTD | PMID:18675900 |
Mapk9 | Rat | oxidopamine | multiple interactions | EXP | | 6480464 | salvin inhibits the reaction [Oxidopamine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25446857 |
Mapk9 | Rat | oxidopamine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | puag-haad inhibits the reaction [Oxidopamine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:18675900 |
Mapk9 | Rat | ozone | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Ozone results in increased phosphorylation of MAPK9 protein | CTD | PMID:19536146 |
Mapk9 | Rat | ozone | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAPK9 mRNA | CTD | PMID:34911549 |
Mapk9 | Rat | paclitaxel | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [esculetin co-treated with Paclitaxel] results in increased expression of MAPK9 protein more ... | CTD | PMID:16051289 and PMID:19944065 |
Mapk9 | Rat | paclitaxel | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Paclitaxel results in increased expression of MAPK9 protein | CTD | PMID:16051289 |
Mapk9 | Rat | paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel analog results in increased expression of MAPK9 mRNA | CTD | PMID:15585946 |
Mapk9 | Rat | paracetamol | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Acetaminophen results in increased phosphorylation of and affects the localization of MAPK9 protein more ... | CTD | PMID:18700144 more ... |
Mapk9 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MAPK9 mRNA | CTD | PMID:33387578 |
Mapk9 | Rat | paracetamol | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Acetaminophen results in increased phosphorylation of MAPK9 protein | CTD | PMID:19931551 more ... |
Mapk9 | Rat | paracetamol | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MAPK9 mRNA | CTD | PMID:27761495 |
Mapk9 | Rat | paracetamol | increases phosphorylation | EXP | | 6480464 | Acetaminophen results in increased phosphorylation of MAPK9 protein | CTD | PMID:26767949 |
Mapk9 | Rat | paracetamol | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of MAPK9 mRNA | CTD | PMID:21420995 and PMID:27761495 |
Mapk9 | Rat | paracetamol | decreases response to substance | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK9 results in decreased susceptibility to Acetaminophen | CTD | PMID:18586006 |
Mapk9 | Rat | paracetamol | increases response to substance | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK9 protein results in increased susceptibility to Acetaminophen | CTD | PMID:18700144 |
Mapk9 | Rat | paraquat | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | MFN2 inhibits the reaction [Paraquat results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:17018646 more ... |
Mapk9 | Rat | paraquat | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Paraquat results in increased phosphorylation of MAPK9 protein | CTD | PMID:28474156 |
Mapk9 | Rat | paraquat | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Paraquat results in increased phosphorylation of MAPK9 protein | CTD | PMID:28215578 |
Mapk9 | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of MAPK9 mRNA | CTD | PMID:18198484 |
Mapk9 | Rat | paraquat | increases phosphorylation | EXP | | 6480464 | Paraquat results in increased phosphorylation of MAPK9 protein | CTD | PMID:16687388 and PMID:28474156 |
Mapk9 | Rat | paraquat | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [Paraquat results in increased phosphorylation of MAPK9 protein] | CTD | PMID:16687388 and PMID:28474156 |
Mapk9 | Rat | parecoxib | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | parecoxib results in increased phosphorylation of MAPK9 protein | CTD | PMID:35917206 |
Mapk9 | Rat | parthenolide | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | parthenolide results in increased expression of MAPK9 mRNA | CTD | PMID:16921510 |
Mapk9 | Rat | PCB138 | affects expression | ISO | MAPK9 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:21703328 |
Mapk9 | Rat | Pentoxifylline | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Pentoxifylline results in increased expression of MAPK9 protein and Pentoxifylline results in increased expression of MAPK9 protein modified form | CTD | PMID:20804743 |
Mapk9 | Rat | phenylephrine | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Phenylephrine] | CTD | PMID:16949803 |
Mapk9 | Rat | phenylephrine | increases phosphorylation | EXP | | 6480464 | Phenylephrine results in increased phosphorylation of MAPK9 protein | CTD | PMID:10727428 |
Mapk9 | Rat | phenylephrine | affects response to substance | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK9 protein affects the susceptibility to Phenylephrine | CTD | PMID:16949803 |
Mapk9 | Rat | phlorizin | decreases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Phlorhizin results in decreased expression of MAPK9 mRNA | CTD | PMID:22538082 |
Mapk9 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Chenodeoxycholic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:17693661 and PMID:25496033 |
Mapk9 | Rat | phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein | CTD | PMID:17693661 more ... |
Mapk9 | Rat | phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein | CTD | PMID:16838270 more ... |
Mapk9 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | CBR1 protein modified form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:19447859 more ... |
Mapk9 | Rat | phorone | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein | CTD | PMID:20423716 |
Mapk9 | Rat | phosgene | multiple interactions | EXP | | 6480464 | ethyl pyruvate inhibits the reaction [Phosgene results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21818760 |
Mapk9 | Rat | phosgene | increases phosphorylation | EXP | | 6480464 | Phosgene results in increased phosphorylation of MAPK9 protein | CTD | PMID:21818760 |
Mapk9 | Rat | phthalic anhydride | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | phthalic anhydride results in increased phosphorylation of MAPK9 protein | CTD | PMID:27129696 |
Mapk9 | Rat | phthalic anhydride | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | phthalic anhydride inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:27129696 |
Mapk9 | Rat | pifithrin-alpha hydrobromide | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:16687611 |
Mapk9 | Rat | pifithrin-alpha hydrobromide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pifithrin inhibits the reaction [Silybin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:16777994 |
Mapk9 | Rat | platycodin D | increases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | platycodin D results in increased activity of MAPK9 protein | CTD | PMID:20412017 |
Mapk9 | Rat | poly(I:C) | multiple interactions | EXP | | 6480464 | [Poly I-C co-treated with HU 211] results in decreased expression of MAPK9 mRNA | CTD | PMID:26923065 |
Mapk9 | Rat | potassium chloride | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Potassium Chloride] | CTD | PMID:16949803 |
Mapk9 | Rat | pramipexole | multiple interactions | EXP | | 6480464 | pramipexole inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:16362428 |
Mapk9 | Rat | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of MAPK9 mRNA | CTD | PMID:19162173 |
Mapk9 | Rat | proanthocyanidin | multiple interactions | EXP | | 6480464 | Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25088297 |
Mapk9 | Rat | procymidone | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | procymidone results in increased expression of MAPK9 mRNA | CTD | PMID:35913088 |
Mapk9 | Rat | prodigiosin | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Prodigiosin results in decreased phosphorylation of MAPK9 protein | CTD | PMID:31077745 |
Mapk9 | Rat | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of MAPK9 mRNA | CTD | PMID:17170212 |
Mapk9 | Rat | prostaglandin F2alpha | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Dinoprost results in increased phosphorylation of MAPK9 protein | CTD | PMID:24333336 |
Mapk9 | Rat | prostaglandin F2alpha | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | resveratrol inhibits the reaction [Dinoprost results in increased phosphorylation of MAPK9 protein] and SRT1720 inhibits the reaction [Dinoprost results in increased phosphorylation of MAPK9 protein] | CTD | PMID:24333336 |
Mapk9 | Rat | protein kinase inhibitor | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Protein Kinase Inhibitors inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26385185 |
Mapk9 | Rat | protein kinase inhibitor | multiple interactions | EXP | | 6480464 | Protein Kinase Inhibitors inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21925238 |
Mapk9 | Rat | pterostilbene | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] and pterostilbene results in decreased phosphorylation of and results in decreased activity of MAPK9 protein | CTD | PMID:19447859 and PMID:24154491 |
Mapk9 | Rat | puerarin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | puerarin results in increased phosphorylation of MAPK9 protein | CTD | PMID:21884717 |
Mapk9 | Rat | pyrrolidine dithiocarbamate | multiple interactions | EXP | | 6480464 | [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein more ... | CTD | PMID:22085843 |
Mapk9 | Rat | pyrrolidine dithiocarbamate | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:15557793 |
Mapk9 | Rat | quercetin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:14688022 more ... |
Mapk9 | Rat | quercetin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of MAPK9 protein | CTD | PMID:14688022 more ... |
Mapk9 | Rat | quercetin | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Quercetin results in increased expression of MAPK9 protein modified form | CTD | PMID:19017364 |
Mapk9 | Rat | reactive oxygen species | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein more ... | CTD | PMID:21135414 and PMID:21391979 |
Mapk9 | Rat | reactive oxygen species | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK9 mRNA]] more ... | CTD | PMID:35833596 |
Mapk9 | Rat | resiniferatoxin | increases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | resiniferatoxin results in increased activity of MAPK9 protein | CTD | PMID:9580328 |
Mapk9 | Rat | resveratrol | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | resveratrol results in decreased phosphorylation of MAPK9 protein | CTD | PMID:23437203 |
Mapk9 | Rat | resveratrol | multiple interactions | EXP | | 6480464 | dorsomorphin inhibits the reaction [Resveratrol results in decreased expression of MAPK9 protein modified form] and Resveratrol inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of MAPK9 protein modified form] | CTD | PMID:27093858 |
Mapk9 | Rat | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MAPK9 protein modified form | CTD | PMID:27093858 |
Mapk9 | Rat | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MAPK9 mRNA | CTD | PMID:19228061 |
Mapk9 | Rat | resveratrol | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | resveratrol results in increased phosphorylation of MAPK9 protein | CTD | PMID:18347188 |
Mapk9 | Rat | resveratrol | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of MAPK9 mRNA more ... | CTD | PMID:18222423 more ... |
Mapk9 | Rat | resveratrol | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [resveratrol results in increased activity of MAPK9 protein] which results in increased phosphorylation of and results in increased activity of TRP53 protein more ... | CTD | PMID:11933078 more ... |
Mapk9 | Rat | resveratrol | increases activity | ISO | Mapk9 (Mus musculus) | 6480464 | resveratrol results in increased activity of MAPK9 protein | CTD | PMID:11933078 |
Mapk9 | Rat | Ro 31-8220 | multiple interactions | EXP | | 6480464 | Ro 31-8220 inhibits the reaction [Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK9 protein] | CTD | PMID:11756236 |
Mapk9 | Rat | rosmarinic acid | decreases phosphorylation | EXP | | 6480464 | Rosmarinic Acid results in decreased phosphorylation of MAPK9 protein | CTD | PMID:28789951 |
Mapk9 | Rat | rotenone | increases activity | ISO | Mapk9 (Mus musculus) | 6480464 | Rotenone results in increased activity of MAPK9 protein | CTD | PMID:11181820 |
Mapk9 | Rat | rotenone | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Rotenone results in increased phosphorylation of MAPK9 protein | CTD | PMID:32368861 |
Mapk9 | Rat | rotenone | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Rotenone results in increased expression of MAPK9 mRNA | CTD | PMID:32368861 |
Mapk9 | Rat | rotenone | increases phosphorylation | EXP | | 6480464 | Rotenone results in increased phosphorylation of MAPK9 protein | CTD | PMID:30472438 |
Mapk9 | Rat | rotenone | multiple interactions | EXP | | 6480464 | 1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased phosphorylation of MAPK9 protein] | CTD | PMID:30472438 |
Mapk9 | Rat | rotenone | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Rotenone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:29906494 |
Mapk9 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of MAPK9 mRNA | CTD | PMID:28374803 |
Mapk9 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of MAPK9 mRNA | CTD | PMID:27900601 |
Mapk9 | Rat | rotenone | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | PSME4 protein promotes the reaction [Rotenone results in increased expression of MAPK9 mRNA] and Rotenone inhibits the reaction [FN1 protein modified form results in increased expression of MAPK9 protein modified form] | CTD | PMID:17395008 and PMID:32368861 |
Mapk9 | Rat | rottlerin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20599481 |
Mapk9 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Buthionine Sulfoximine results in decreased phosphorylation of MAPK9 protein | CTD | PMID:17191120 |
Mapk9 | Rat | salubrinal | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20686688 |
Mapk9 | Rat | salubrinal | multiple interactions | EXP | | 6480464 | [salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:21147958 |
Mapk9 | Rat | sanguinarine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [sanguinarine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:19135517 |
Mapk9 | Rat | sanguinarine | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | sanguinarine results in increased phosphorylation of MAPK9 protein | CTD | PMID:19135517 |
Mapk9 | Rat | SB 203580 | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [4-vinyl-2 more ... | CTD | PMID:16818652 and PMID:30653946 |
Mapk9 | Rat | selenium atom | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Selenium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26187450 |
Mapk9 | Rat | serpentine asbestos | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Asbestos and Serpentine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:24735948 |
Mapk9 | Rat | serpentine asbestos | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Asbestos and Serpentine results in increased phosphorylation of MAPK9 protein | CTD | PMID:24735948 |
Mapk9 | Rat | Shikonin | multiple interactions | EXP | | 6480464 | shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of MAPK9 protein] | CTD | PMID:35028790 |
Mapk9 | Rat | silibinin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pifithrin inhibits the reaction [Silybin results in increased phosphorylation of MAPK9 protein] and pyrazolanthrone inhibits the reaction [Silybin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:16777994 |
Mapk9 | Rat | silibinin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Silybin results in increased phosphorylation of MAPK9 protein | CTD | PMID:16777994 |
Mapk9 | Rat | silicon dioxide | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Silicon Dioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:27616297 |
Mapk9 | Rat | silicon dioxide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of MAPK9 protein] and pyrazolanthrone inhibits the reaction [Silicon Dioxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:35689653 |
Mapk9 | Rat | silicon dioxide | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:26163174 more ... |
Mapk9 | Rat | silver atom | increases phosphorylation | EXP | | 6480464 | Silver results in increased phosphorylation of MAPK9 protein | CTD | PMID:26702581 |
Mapk9 | Rat | silver(0) | increases phosphorylation | EXP | | 6480464 | Silver results in increased phosphorylation of MAPK9 protein | CTD | PMID:26702581 |
Mapk9 | Rat | simvastatin | increases activity | ISO | Mapk9 (Mus musculus) | 6480464 | Simvastatin results in increased activity of MAPK9 protein | CTD | PMID:15187114 |
Mapk9 | Rat | sodium arsenate | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | sodium arsenate results in increased phosphorylation of MAPK9 protein | CTD | PMID:12221076 |
Mapk9 | Rat | sodium arsenite | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of MAPK9 protein modified form | CTD | PMID:28757890 |
Mapk9 | Rat | sodium arsenite | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of MAPK9 mRNA | CTD | PMID:38568856 |
Mapk9 | Rat | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of MAPK9 protein | CTD | PMID:27966075 |
Mapk9 | Rat | sodium arsenite | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | sodium arsenite results in increased phosphorylation of MAPK9 protein | CTD | PMID:16973625 more ... |
Mapk9 | Rat | sodium arsenite | affects expression | ISO | Mapk9 (Mus musculus) | 6480464 | sodium arsenite affects the expression of MAPK9 | CTD | PMID:25367288 |
Mapk9 | Rat | sodium arsenite | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | CDKN1B protein affects the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:16973625 more ... |
Mapk9 | Rat | sodium arsenite | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | sodium arsenite results in increased phosphorylation of MAPK9 protein | CTD | PMID:12482858 more ... |
Mapk9 | Rat | sodium arsenite | increases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | sodium arsenite results in increased activity of MAPK9 protein | CTD | PMID:22706169 |
Mapk9 | Rat | sodium arsenite | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA more ... | CTD | PMID:12634122 more ... |
Mapk9 | Rat | sodium arsenite | increases phosphorylation | EXP | | 6480464 | sodium arsenite results in increased phosphorylation of MAPK9 protein | CTD | PMID:11408547 more ... |
Mapk9 | Rat | sodium arsenite | increases activity | EXP | | 6480464 | sodium arsenite results in increased activity of MAPK9 protein | CTD | PMID:17658681 |
Mapk9 | Rat | sodium arsenite | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:17658681 more ... |
Mapk9 | Rat | sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of MAPK9 mRNA | CTD | PMID:11960910 |
Mapk9 | Rat | sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of MAPK9 mRNA | CTD | PMID:25993096 |
Mapk9 | Rat | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of MAPK9 mRNA | CTD | PMID:12325037 |
Mapk9 | Rat | sorafenib | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Bortezomib co-treated with Sorafenib] results in increased phosphorylation of MAPK9 protein more ... | CTD | PMID:16985072 and PMID:30187994 |
Mapk9 | Rat | sorafenib | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Sorafenib results in decreased phosphorylation of MAPK9 protein | CTD | PMID:30187994 |
Mapk9 | Rat | SR 144528 | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | SR 144528 inhibits the reaction [Dronabinol results in increased phosphorylation of MAPK9 protein] | CTD | PMID:24184660 |
Mapk9 | Rat | stattic | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | stattic inhibits the reaction [arsenic trichloride results in increased phosphorylation of MAPK9 protein] | CTD | PMID:24434654 |
Mapk9 | Rat | streptozocin | multiple interactions | EXP | | 6480464 | chromium mesoporphyrin inhibits the reaction [Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA]] and Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA] | CTD | PMID:19190261 |
Mapk9 | Rat | streptozocin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAPK9 protein and Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26522834 |
Mapk9 | Rat | streptozocin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Streptozocin inhibits the reaction [AKR1B1 protein results in increased phosphorylation of MAPK9 protein] | CTD | PMID:25541468 |
Mapk9 | Rat | streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of MAPK9 mRNA | CTD | PMID:19190261 |
Mapk9 | Rat | sucrose | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Oligosaccharides co-treated with Sucrose co-treated with Dietary Fats] affects the expression of MAPK9 mRNA | CTD | PMID:31181236 |
Mapk9 | Rat | sulfasalazine | increases phosphorylation | EXP | | 6480464 | Sulfasalazine results in increased phosphorylation of MAPK9 protein | CTD | PMID:15633128 |
Mapk9 | Rat | sulfates | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Soot co-treated with Sulfates] affects the methylation of MAPK9 promoter | CTD | PMID:25395096 |
Mapk9 | Rat | sulfates | affects methylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Sulfates affects the methylation of MAPK9 promoter | CTD | PMID:25395096 |
Mapk9 | Rat | sulforaphane | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | sulforaphane inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of MAPK9 protein] more ... | CTD | PMID:25933243 and PMID:32387680 |
Mapk9 | Rat | sunitinib | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of MAPK9 mRNA | CTD | PMID:31533062 |
Mapk9 | Rat | superoxide | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Superoxides results in increased phosphorylation of MAPK9 protein | CTD | PMID:33290831 |
Mapk9 | Rat | surfactin | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | surfactin peptide results in increased phosphorylation of MAPK9 protein | CTD | PMID:34850538 |
Mapk9 | Rat | surfactin | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [surfactin peptide results in increased phosphorylation of MAPK9 protein] and KIRA6 inhibits the reaction [surfactin peptide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:34850538 |
Mapk9 | Rat | surfactin C | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [surfactin peptide results in increased phosphorylation of MAPK9 protein] and KIRA6 inhibits the reaction [surfactin peptide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:34850538 |
Mapk9 | Rat | surfactin C | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | surfactin peptide results in increased phosphorylation of MAPK9 protein | CTD | PMID:34850538 |
Mapk9 | Rat | syringic acid | multiple interactions | EXP | | 6480464 | syringic acid inhibits the reaction [Valproic Acid results in increased expression of MAPK9 mRNA] | CTD | PMID:35543257 |
Mapk9 | Rat | tamoxifen | affects expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Tamoxifen affects the expression of MAPK9 mRNA | CTD | PMID:14699072 |
Mapk9 | Rat | tamoxifen | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Tamoxifen inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased phosphorylation of MAPK9 protein] and Tamoxifen inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK9 protein] | CTD | PMID:23038002 |
Mapk9 | Rat | Tanshinone I | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:29906494 |
Mapk9 | Rat | taurine | multiple interactions | EXP | | 6480464 | [[Taurine binds to Zinc] which co-treated with poly(N-vinylpyrrolidine)] results in decreased expression of MAPK9 protein modified form more ... | CTD | PMID:26335259 and PMID:27501764 |
Mapk9 | Rat | taurine | decreases expression | EXP | | 6480464 | Taurine results in decreased expression of MAPK9 protein modified form | CTD | PMID:27501764 |
Mapk9 | Rat | taurocholic acid | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | NR1H4 gene mutant form promotes the reaction [Taurocholic Acid results in increased phosphorylation of MAPK9 protein] | CTD | PMID:28505368 |
Mapk9 | Rat | temozolomide | decreases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of MAPK9 mRNA | CTD | PMID:31758290 |
Mapk9 | Rat | TEMPO | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | TEMPO inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] | CTD | PMID:33290831 |
Mapk9 | Rat | tert-butyl hydroperoxide | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein | CTD | PMID:20423716 |
Mapk9 | Rat | tert-butyl hydroperoxide | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:28063877 |
Mapk9 | Rat | tert-butyl hydroperoxide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein] | CTD | PMID:28063877 |
Mapk9 | Rat | tetracaine | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:11981161 |
Mapk9 | Rat | tetracaine | increases phosphorylation | EXP | | 6480464 | Tetracaine results in increased phosphorylation of MAPK9 protein | CTD | PMID:11981161 |
Mapk9 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MAPK9 protein | CTD | PMID:18081878 |
Mapk9 | Rat | tetrachloromethane | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | [Dietary Fats co-treated with Carbon Tetrachloride] results in increased phosphorylation of MAPK9 protein more ... | CTD | PMID:20589743 and PMID:35745142 |
Mapk9 | Rat | tetrachloromethane | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased phosphorylation of MAPK9 protein | CTD | PMID:20589743 and PMID:21291945 |
Mapk9 | Rat | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of MAPK9 mRNA | CTD | PMID:16239168 |
Mapk9 | Rat | tetramethylpyrazine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | tetramethylpyrazine inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26404762 |
Mapk9 | Rat | thapsigargin | increases phosphorylation | EXP | | 6480464 | Thapsigargin results in increased phosphorylation of MAPK9 protein | CTD | PMID:21147958 |
Mapk9 | Rat | Theaflavin 3,3'-digallate | decreases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | theaflavin-3 and 3'-digallate results in decreased phosphorylation of MAPK9 protein | CTD | PMID:30874838 |
Mapk9 | Rat | thimerosal | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Thimerosal results in increased phosphorylation of MAPK9 protein | CTD | PMID:17698513 |
Mapk9 | Rat | titanium dioxide | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | [Ferrosoferric Oxide binds to titanium dioxide] which results in increased phosphorylation of MAPK9 protein | CTD | PMID:30098274 |
Mapk9 | Rat | titanium dioxide | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | titanium dioxide results in increased phosphorylation of MAPK9 protein | CTD | PMID:30098274 |
Mapk9 | Rat | tofacitinib | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | tofacitinib inhibits the reaction [OSM protein results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21548952 |
Mapk9 | Rat | toluene 2,4-diisocyanate | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Toluene 2 and 4-Diisocyanate results in increased phosphorylation of MAPK9 protein | CTD | PMID:33075463 |
Mapk9 | Rat | toluene 2,4-diisocyanate | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [Toluene 2 and 4-Diisocyanate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:33075463 |
Mapk9 | Rat | toluene 2,4-diisocyanate | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Toluene 2 and 4-Diisocyanate results in increased phosphorylation of MAPK9 protein | CTD | PMID:33075463 |
Mapk9 | Rat | toluene 2,4-diisocyanate | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [Toluene 2 and 4-Diisocyanate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:33075463 |
Mapk9 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of MAPK9 mRNA | CTD | PMID:19448997 |
Mapk9 | Rat | trichostatin A | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | DUSP1 mutant form inhibits the reaction [trichostatin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]] and trichostatin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:21911040 |
Mapk9 | Rat | triclosan | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Triclosan inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:19874453 |
Mapk9 | Rat | triclosan | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Triclosan results in increased phosphorylation of MAPK9 protein] and pyrazolanthrone inhibits the reaction [Triclosan results in increased phosphorylation of MAPK9 protein] | CTD | PMID:34160118 |
Mapk9 | Rat | triclosan | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | Triclosan results in increased phosphorylation of MAPK9 protein | CTD | PMID:34160118 |
Mapk9 | Rat | trifluoperazine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
Mapk9 | Rat | trifluoperazine | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
Mapk9 | Rat | trifluoperazine | multiple interactions | EXP | | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] | CTD | PMID:21544200 |
Mapk9 | Rat | trimellitic anhydride | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | trimellitic anhydride results in increased phosphorylation of MAPK9 protein | CTD | PMID:27129696 |
Mapk9 | Rat | trimellitic anhydride | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | trimellitic anhydride inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | CTD | PMID:27129696 |
Mapk9 | Rat | trimethyltin | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | trimethyltin results in increased phosphorylation of MAPK9 protein | CTD | PMID:26756313 |
Mapk9 | Rat | trimethyltin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | magnolol inhibits the reaction [trimethyltin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26756313 |
Mapk9 | Rat | tunicamycin | increases phosphorylation | EXP | | 6480464 | Tunicamycin results in increased phosphorylation of MAPK9 protein | CTD | PMID:21147958 |
Mapk9 | Rat | tyrphostin AG 1478 | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | RTKI cpd inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26514923 |
Mapk9 | Rat | ursolic acid | multiple interactions | EXP | | 6480464 | bisphenol A diglycidyl ether inhibits the reaction [Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK9 protein]] and Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:27274199 |
Mapk9 | Rat | valproic acid | increases expression | ISO | MAPK9 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MAPK9 mRNA | CTD | PMID:23179753 more ... |
Mapk9 | Rat | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of MAPK9 mRNA | CTD | PMID:35543257 |
Mapk9 | Rat | valproic acid | multiple interactions | EXP | | 6480464 | Silymarin inhibits the reaction [Valproic Acid results in increased expression of MAPK9 mRNA] and syringic acid inhibits the reaction [Valproic Acid results in increased expression of MAPK9 mRNA] | CTD | PMID:35543257 |
Mapk9 | Rat | valproic acid | increases phosphorylation | EXP | | 6480464 | Valproic Acid results in increased phosphorylation of MAPK9 protein | CTD | PMID:23378038 |
Mapk9 | Rat | vincaleukoblastine | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of MAPK9 protein] | CTD | PMID:12221076 |
Mapk9 | Rat | vincaleukoblastine | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | Vinblastine results in increased phosphorylation of MAPK9 protein | CTD | PMID:12221076 |
Mapk9 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of MAPK9 mRNA | CTD | PMID:19015723 |
Mapk9 | Rat | vinclozolin | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | vinclozolin results in increased expression of MAPK9 mRNA | CTD | PMID:36642194 |
Mapk9 | Rat | vinclozolin | affects expression | ISO | Mapk9 (Mus musculus) | 6480464 | vinclozolin affects the expression of MAPK9 mRNA | CTD | PMID:34182078 |
Mapk9 | Rat | WIN 55212-2 | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | (3R)-((2 more ... | CTD | PMID:20619260 |
Mapk9 | Rat | wogonin | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | wogonin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK9 protein] | CTD | PMID:23362215 |
Mapk9 | Rat | wortmannin | multiple interactions | EXP | | 6480464 | Wortmannin inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased phosphorylation of MAPK9 protein] | CTD | PMID:10611455 |
Mapk9 | Rat | xanthohumol | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | xanthohumol results in increased phosphorylation of MAPK9 protein | CTD | PMID:35229981 |
Mapk9 | Rat | zinc acetate | multiple interactions | EXP | | 6480464 | [Taurine co-treated with Zinc Acetate] results in decreased expression of MAPK9 protein modified form | CTD | PMID:27501764 |
Mapk9 | Rat | zinc atom | multiple interactions | EXP | | 6480464 | [[Taurine binds to Zinc] which co-treated with poly(N-vinylpyrrolidine)] results in decreased expression of MAPK9 protein modified form and [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26335259 and PMID:27501764 |
Mapk9 | Rat | zinc dichloride | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | zinc chloride inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] | CTD | PMID:20423716 |
Mapk9 | Rat | zinc oxide | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | Zinc Oxide results in increased expression of MAPK9 mRNA | CTD | PMID:33599401 |
Mapk9 | Rat | zinc(0) | multiple interactions | EXP | | 6480464 | [[Taurine binds to Zinc] which co-treated with poly(N-vinylpyrrolidine)] results in decreased expression of MAPK9 protein modified form and [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] | CTD | PMID:26335259 and PMID:27501764 |